10.69
Schlusskurs vom Vortag:
$10.29
Offen:
$10.29
24-Stunden-Volumen:
535.95K
Relative Volume:
0.88
Marktkapitalisierung:
$624.75M
Einnahmen:
$1.12B
Nettoeinkommen (Verlust:
$55.30M
KGV:
11.25
EPS:
0.95
Netto-Cashflow:
$-30.30M
1W Leistung:
+11.59%
1M Leistung:
+9.42%
6M Leistung:
-42.96%
1J Leistung:
-29.58%
Embecta Corp Stock (EMBC) Company Profile
Firmenname
Embecta Corp
Sektor
Telefon
(862) 401-0000
Adresse
1209 ORANGE STREET, WILMINGTON
Vergleichen Sie EMBC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
EMBC
Embecta Corp
|
10.69 | 559.88M | 1.12B | 55.30M | -30.30M | 0.95 |
![]()
ISRG
Intuitive Surgical Inc
|
511.00 | 183.59B | 8.71B | 2.48B | 1.75B | 6.82 |
![]()
BDX
Becton Dickinson Co
|
181.28 | 51.10B | 20.87B | 1.50B | 2.59B | 5.24 |
![]()
ALC
Alcon Inc
|
88.66 | 42.51B | 9.93B | 1.12B | 1.58B | 2.25 |
![]()
RMD
Resmed Inc
|
267.40 | 36.95B | 5.02B | 1.31B | 1.56B | 8.91 |
![]()
WST
West Pharmaceutical Services Inc
|
218.90 | 15.88B | 2.90B | 467.20M | 306.90M | 6.37 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-04-10 | Eingeleitet | Mizuho | Neutral |
2024-12-02 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
2024-11-27 | Hochstufung | BTIG Research | Neutral → Buy |
2023-10-20 | Eingeleitet | Wolfe Research | Peer Perform |
2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
2022-09-08 | Eingeleitet | BTIG Research | Neutral |
2022-08-01 | Eingeleitet | Morgan Stanley | Equal-Weight |
2022-06-21 | Eingeleitet | BofA Securities | Underperform |
Alle ansehen
Embecta Corp Aktie (EMBC) Neueste Nachrichten
What drives Embecta Corp. stock priceExceptional market positioning - jammulinksnews.com
Embecta Corp. Stock Analysis and ForecastOverwhelming financial success - jammulinksnews.com
(EMBC) Technical Data - news.stocktradersdaily.com
What analysts say about Embecta Corp. stockOutstanding growth strategies - Autocar Professional
Is Embecta Corp. a good long term investmentConsistent high-performance stocks - printweek.in
BTIG Lowers PT on Embecta Corp. (EMBC) to $25, Keeps a Buy Rating - MSN
Mizuho Lowers PT on Embecta Corp. (EMBC) to $13 From $15, Keeps a Neutral Rating - MSN
13 Cheap Stocks with Huge Upside Potential - Insider Monkey
Is Embecta Corp. a Contrarian Gem in a World Obsessed with Energy? - AInvest
How to Take Advantage of moves in (EMBC) - news.stocktradersdaily.com
Sentiment Still Eluding Embecta Corp. (NASDAQ:EMBC) - simplywall.st
Embecta Corp. (EMBC) Lowered FY25 Guidance Amid Foreign Exchange Challenges - Yahoo Finance
Embecta raises adjusted EBITDA margin outlook for FY 2025 amid restructuring and debt reduction - MSN
Pen Needles Market to Hit USD 3.08 Billion by 2030 with 9.2% CAGR | MarketsandMarkets™NORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Transcript : Embecta Corp. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener
Embecta(EMBC) Shares Plunge 1.90% to Record Low - AInvest
InvestingPro’s bearish call on Embecta proves accurate with 48% decline By Investing.com - Investing.com Nigeria
Embecta stock hits 52-week low at $10.26 amid market challenges By Investing.com - Investing.com South Africa
Embecta stock hits 52-week low at $10.26 amid market challenges - Investing.com Australia
BofA cuts Embecta stock price target to $18 from $20 By Investing.com - Investing.com South Africa
BofA cuts Embecta stock price target to $18 from $20 - Investing.com India
Embecta Corp (EMBC) Stock Price Down 6.22% on May 28 - GuruFocus
embecta to Participate in Investor Events - The Manila Times
embecta to Participate in Investor Events - GlobeNewswire Inc.
Independent Non-Executive Chairman of Embecta Picks Up 13% More Stock - Yahoo Finance
Insider Buying: David Melcher Acquires 10,000 Shares of Embecta Corp (EMBC) - GuruFocus
Director Makes Bold Move with Major Stock Purchase in Embecta Corporation! - TipRanks
Finanzdaten der Embecta Corp-Aktie (EMBC)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):